← Back to home

ENDOMETRIAL ATYPICAL HYPERPLASIA/ENDOMETRIOID INTRAEPITHELIAL NEOPLASIA

Clinical trials for ENDOMETRIAL ATYPICAL HYPERPLASIA/ENDOMETRIOID INTRAEPITHELIAL NEOPLASIA explained in plain language.

Never miss a new study

Get alerted when new ENDOMETRIAL ATYPICAL HYPERPLASIA/ENDOMETRIOID INTRAEPITHELIAL NEOPLASIA trials appear

Sign up with your email to follow new studies for ENDOMETRIAL ATYPICAL HYPERPLASIA/ENDOMETRIOID INTRAEPITHELIAL NEOPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

New drug combo tested to halt uterine Pre-Cancer before it turns deadly

Disease control Ongoing

This study is testing if adding a common diabetes drug, metformin, to the standard hormone therapy (megestrol acetate) works better to control a uterine pre-cancer condition. It involves 51 women who are already scheduled for a hysterectomy or IUD placement. The goal is to see if…

Matched conditions: ENDOMETRIAL ATYPICAL HYPERPLASIA/ENDOMETRIOID INTRAEPITHELIAL NEOPLASIA

Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

ENDOMETRIAL ATYPICAL HYPERPLASIA/ENDOMETRIOID INTRAEPITHELIAL NEOPLASIA

Get alerted when new ENDOMETRIAL ATYPICAL HYPERPLASIA/ENDOMETRIOID INTRAEPITHELIAL NEOPLASIA trials appear

New drug combo tested to halt uterine Pre-Cancer before it turns deadly